Antibody derivatization and conjugation strategies: application in preparation of stealth immunoliposome to target chemotherapeutics to tumor. - Wikidata - awgldk - TriplyDB

Antibody derivatization and conjugation strategies: application in preparation of stealth immunoliposome to target chemotherapeutics to tumor.

Antibody derivatization and conjugation strategies: application in preparation of stealth immunoliposome to target chemotherapeutics to tumor.

http://www.wikidata.org/entity/Q37811459

about

The potential of liposomes with carbonic anhydrase IX to deliver anticancer ingredients to cancer cells in vivo Assembly of bio-nanoparticles for double controlled drug release Designer lipids for drug delivery: from heads to tails.Ultrasound-mediated gene and drug delivery using a microbubble-liposome particle system Acoustic droplet vaporization in biology and medicine.Recent trends in multifunctional liposomal nanocarriers for enhanced tumor targeting Sonodynamic excitation of Rose Bengal for eradication of gram-positive and gram-negative bacteria Bifunctional chelates optimized for molecular MRI Conditional internalization of PEGylated nanomedicines by PEG engagers for triple negative breast cancer therapy High-affinity peptide against MT1-MMP for in vivo tumor imaging Investigation of glucose-modified liposomes using polyethylene glycols with different chain lengths as the linkers for brain targeting.Molecular targeting of CEACAM6 using antibody probes of different sizes.Liposomes functionalized to overcome the blood-brain barrier and to target amyloid-β peptide: the chemical design affects the permeability across an in vitro model.A light-controlled switch after dual targeting of proliferating tumor cells via the membrane receptor EGFR and the nuclear protein Ki-67 Non-destructive and selective imaging of the functionally active, pro-invasive membrane type-1 matrix metalloproteinase (MT1-MMP) enzyme in cancer cells Comparison of anti-EGFR-Fab' conjugated immunoliposomes modified with two different conjugation linkers for siRNa delivery in SMMC-7721 cells Surface engineering of liposomes for stealth behavior.Bioceramics: from bone regeneration to cancer nanomedicine.In vivo gene delivery by nonviral vectors: overcoming hurdles?Antibody-drug conjugates - a perfect synergy.Oligonucleotide conjugates for therapeutic applications.Application of traditional Chinese medicine preparation in targeting drug delivery system.Synthetic multivalency for biological applications.Antibody-targeted biodegradable nanoparticles for cancer therapy.The promotion of salinomycin delivery to hepatocellular carcinoma cells through EGFR and CD133 aptamers conjugation by PLGA nanoparticles.Enhancement of cancer specific delivery using ultrasound active bio-originated particles.Improved anticancer delivery of paclitaxel by albumin surface modification of PLGA nanoparticles.Poly(lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133+ osteosarcoma cancer stem cells.Carbonic anhydrase IX-directed immunoliposomes for targeted drug delivery to human lung cancer cells in vitro.Anti-neuropilin 1 antibody Fab' fragment conjugated liposomal docetaxel for active targeting of tumours.Is an alternative drug delivery system needed for docetaxel? The role of controlling epimerization in formulations and beyond.Engineering liposomal nanoparticles for targeted gene therapy.Overcoming nonviral gene delivery barriers: perspective and future.Multifunctional Transmembrane Protein Ligands for Cell-Specific Targeting of Plasma Membrane-Derived Vesicles Gefitinib-loaded DSPE-PEG2000 nanomicelles with CD133 aptamers target lung cancer stem cells.Targeted delivery system of nanobiomaterials in anticancer therapy: from cells to clinics.Pulmonary delivery of triptolide-loaded liposomes decorated with anti-carbonic anhydrase IX antibody for lung cancer therapy.Etoposide-loaded immunoliposomes as active targeting agents for GD2-positive malignancies Functionalized liposome purification via Liposome Extruder Purification (LEP).Surface Functionalization and Targeting Strategies of Liposomes in Solid Tumor Therapy: A Review.

P2860

Q26827175-7633EA98-3B8D-4F6B-9B28-8DD0C0BA5C83 Q28536927-78E13492-C0DC-4107-A55F-632EE1322C54 Q30402374-5BBBB77D-1E76-4493-97AA-EEA0C1BA95EC Q30430371-9F02BC62-7E30-4A95-896B-DF3290690F5B Q30445721-62A46C9F-F92C-4478-AF18-0540052A5F76 Q30456053-1B6E5716-60F4-4602-A375-1FA536CFABCE Q30456218-83A1F3D7-DFCA-4252-99EA-5A7C85731598 Q30831437-78431845-CC34-4D62-9BD7-CBBFD1ACB297 Q33802940-CEFB9458-0CF6-442E-AF83-51918FB13D20 Q33812205-BF607448-67B4-44C2-A4A3-BB2AD7C1E3F2 Q34139891-785F56B9-B786-4753-996E-EB5625F592C4 Q36044493-AB6F3E22-C17E-40AD-8A41-1FF1CCB011BE Q36839343-C1752201-5A8C-4123-A135-1850000D11E5 Q36953748-A0E3D6DA-C1FA-4BB6-BDC6-CEDF7F22FCDC Q37012504-7A3D8599-28E6-493F-953C-2B50075F65FB Q37157241-121E3C38-9F3E-4335-BB0E-17BF08A0CE44 Q37415968-489F3482-F171-4A06-A4D8-98419C9EFCFB Q37947163-A0D753CD-311E-4CEF-8328-D722B7CFBC0A Q38004708-B18C17B3-021E-4A0D-A3B6-BEDC19E78704 Q38014923-9C523C5E-AAF7-4A87-AB62-7311E355A790 Q38123854-BD7E0019-D800-42A9-AA76-5319FB097119 Q38194622-1AC0CBB4-723C-44D8-AF46-524B1541D4A6 Q38598783-E9FCCF82-E1DA-4A33-8B3C-0CA74B272B44 Q38665261-C5C9FB1B-F5A6-4646-92AC-F38D408FA22C Q38857110-E58C642A-E171-4093-A899-1678DF5521B1 Q38876997-7B1157F7-2121-4D61-A5C6-6D48A651AC6C Q38883410-BFCD395C-A33D-4E90-8161-6662E3F95204 Q38890185-D5F450FE-5373-4DDF-BB7C-A5AB5AB18658 Q38968651-F87F882D-93DB-4EB7-B78F-BEFAD6C4889C Q39001270-FC17F6F8-B7A2-4B9B-B5EE-345492BA6DA3 Q39140852-2C9ABECB-3D3D-4810-B287-B1977992B04A Q39306702-BCBC697C-2A3D-41EB-8D9E-335A8E09F9F4 Q39339350-FC7360A1-C881-4CA0-8736-C927E242004D Q41098832-2C066C9B-3490-4454-978D-2C3125CB06B3 Q41571715-4262BBF3-3EDE-47EE-BBE8-74934AF2B596 Q41953738-75302F44-46A7-4403-AC69-D67EF3922B52 Q42269128-99EE0933-7424-4DCC-BFBF-6D4B8EF74759 Q42737898-5F6E89D0-A84A-49CB-9DA8-1D21D16AA01F Q46304429-35438A4F-DA34-4BC9-8896-0BE3E55519B2 Q47190264-15FC414C-3CDC-47C9-BBE4-CBF981F03B31

P2860

Antibody derivatization and conjugation strategies: application in preparation of stealth immunoliposome to target chemotherapeutics to tumor.

http://www.wikidata.org/entity/Q37811459

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

Antibody derivatization and co ...... et chemotherapeutics to tumor.

@en

Antibody derivatization and co ...... et chemotherapeutics to tumor.

@nl

type

label

Antibody derivatization and co ...... et chemotherapeutics to tumor.

@en

Antibody derivatization and co ...... et chemotherapeutics to tumor.

@nl

prefLabel

Antibody derivatization and co ...... et chemotherapeutics to tumor.

@en

Antibody derivatization and co ...... et chemotherapeutics to tumor.

@nl

P1433

Q37811459-0C65F069-0792-430F-AEEC-3E41BF247EE6

P1476

Q37811459-059B3BB6-E78C-4E47-82D1-25330F53EC6C

P2093

Q37811459-0BF29D76-62E3-4D3D-A787-F343CB9BDD66

Q37811459-0FD5133F-98A4-45BA-A6BD-ADB575E418BE

Q37811459-24D9E66C-C134-4EE6-BBDF-D45E0FEF9568

Q37811459-61BFB3F5-770E-44B5-B51D-D246715B5A14

Q37811459-83C479DF-6D69-4536-8A1B-184D96129485

Q37811459-AA053899-656F-4BD8-8230-D7434283B7A1

Q37811459-AE9707CD-95CF-461E-A72A-ADAE0694B400

Q37811459-EA811172-1AB5-480B-8AC1-1527567E9946

P304

Q37811459-02FCA73D-99F5-4838-9CBB-62AACE4A8A40

P31

Q37811459-764FCC96-DB91-4C6F-A8EC-2E199E2F456D

P356

Q37811459-63F5B988-A9EF-4027-A381-75FDCE5DF4ED

P407

Q37811459-A5B0FD93-6C50-4A92-91E9-1606CD72295C

P433

Q37811459-26FABFE1-2F6B-4EEC-8580-D04F3550679B

P478

Q37811459-475C5B91-42F2-4ED3-853A-ACC1E7D01684

P577

Q37811459-32C5C6B9-29EB-4569-8CEC-60624D448AFE

P5875

Q37811459-7C4AF364-FCA5-4885-B15D-005059545CD0

P698

Q37811459-86A625C3-2E13-48B6-92A8-A5B1A2D1E9CB

P921

Q37811459-53358654-C279-4616-A0C0-5FB66A09591F

Q37811459-E7E5B60F-50FA-47F8-884B-7D24E26545F0

P356

J.JCONREL.2010.11.002

P1433

Journal of Controlled Release

P1476

Antibody derivatization and co ...... et chemotherapeutics to tumor.

@en

P2093

Arehalli S Manjappa

http://www.w3.org/2001/XMLSchema#string

Biswarup Nanda

http://www.w3.org/2001/XMLSchema#string

Chennakesavulu Sidda

http://www.w3.org/2001/XMLSchema#string

Kiran R Chaudhari

http://www.w3.org/2001/XMLSchema#string

Krutika K Sawant

http://www.w3.org/2001/XMLSchema#string

Makam P Venkataraju

http://www.w3.org/2001/XMLSchema#string

Prudhviraju Dantuluri

http://www.w3.org/2001/XMLSchema#string

Rayasa S Ramachandra Murthy

http://www.w3.org/2001/XMLSchema#string

P304

2-22

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JCONREL.2010.11.002

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

150

http://www.w3.org/2001/XMLSchema#string

P577

2010-11-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49626412

http://www.w3.org/2001/XMLSchema#string

P698

21095210

http://www.w3.org/2001/XMLSchema#string

P921